Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
96 studies found for:    apatinib
Show Display Options
Rank Status Study
1 Not yet recruiting Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
Condition: Soft Tissue Sarcoma, Adult, Stage II
Intervention: Drug: Apatinib
2 Completed Effect of Rifampicin on the Pharmacokinetics of Apatinib
Condition: Neoplasms
Interventions: Drug: Apatinib Mesylate Tablets;   Drug: Rifampicin Capsules
3 Not yet recruiting Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: Apatinib Mesylate tablet
4 Not yet recruiting A Phase II Study of Apatinib in STS Patients
Condition: Soft Tissue Sarcoma
Intervention: Drug: apatinib
5 Recruiting Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients
Condition: Colorectal Neoplasms
Intervention: Drug: Apatinib and XELOX combined treatment group
6 Recruiting Apatinib for Metastatic Esophageal Cancer.
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Apatinib
Intervention: Drug: Apatinib
7 Recruiting An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib Mesylate tablet combined with S-1 capsules
8 Not yet recruiting A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib Mesylate Tablets
9 Recruiting The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: apatinib single agent
10 Recruiting Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib single agent arm
11 Recruiting Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: Apatinib
12 Recruiting Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib
13 Completed Effect of Itraconazole on the Pharmacokinetics of Apatinib
Condition: Neoplasms
Interventions: Drug: Apatinib Mesylate Tablets;   Drug: Itraconazole Capsules
14 Not yet recruiting A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: SHR-1210;   Drug: Apatinib
15 Recruiting Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial
Conditions: Soft Tissue Sarcoma Adult;   Advanced Cancer
Intervention: Drug: Apatinib
16 Recruiting Apatinib for Advanced Non-squamous Head and Neck Cancer
Condition: Head and Neck Neoplasms
Intervention: Drug: Apatinib
17 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
18 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
Condition: Adenocarcinoma of Lung
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
19 Not yet recruiting Apatinib for the Elderly Advanced Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Apatinib
20 Recruiting The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer
Condition: Apatinib in Maintenance Treatment
Intervention: Drug: Apatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.